The PTK7 and ROR2 Protein Receptors Interact in the Vertebrate WNT/Planar Cell Polarity (PCP) Pathway.

J Biol Chem

From the CRCM, Cell Polarity, Cell Signaling, and Cancer "Equipe Labellisée Ligue Contre le Cancer", INSERM, U1068, 13009 Marseille, France, the Institut Paoli-Calmettes, 13009 Marseille, France, the Aix-Marseille Université, 13284 Marseille, France, the CNRS, UMR7258, 13009 Marseille, France, and

Published: December 2015

The non-canonical WNT/planar cell polarity (WNT/PCP) pathway plays important roles in morphogenetic processes in vertebrates. Among WNT/PCP components, protein tyrosine kinase 7 (PTK7) is a tyrosine kinase receptor with poorly defined functions lacking catalytic activity. Here we show that PTK7 associates with receptor tyrosine kinase-like orphan receptor 2 (ROR2) to form a heterodimeric complex in mammalian cells. We demonstrate that PTK7 and ROR2 physically and functionally interact with the non-canonical WNT5A ligand, leading to JNK activation and cell movements. In the Xenopus embryo, Ptk7 functionally interacts with Ror2 to regulate protocadherin papc expression and morphogenesis. Furthermore, we show that Ptk7 is required for papc activation induced by Wnt5a. Interestingly, we find that Wnt5a stimulates the release of the tagged Ptk7 intracellular domain, which can translocate into the nucleus and activate papc expression. This study reveals novel molecular mechanisms of action of PTK7 in non-canonical WNT/PCP signaling that may promote cell and tissue movements.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683276PMC
http://dx.doi.org/10.1074/jbc.M115.697615DOI Listing

Publication Analysis

Top Keywords

ptk7
8
ptk7 ror2
8
wnt/planar cell
8
cell polarity
8
tyrosine kinase
8
papc expression
8
ror2 protein
4
protein receptors
4
receptors interact
4
interact vertebrate
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!